Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Otago researchers receive new joint research funding


Thursday 2 March 2017

Otago researchers receive new joint pharmaceuticals research funding

Researchers from University of Otago are among the first recipients of two new grants from PHARMAC and the Health Research Council of New Zealand (HRC).

Dr Lianne Parkin of the Department of Preventive and Social Medicine receives a grant worth more than $210,000 for research into metformin use by people with diabetes. This drug is the first-line treatment for type 2 diabetes, however overseas research shows that many patients do not use it as prescribed.

Dr Parkin and colleagues will explore how to improve the way New Zealanders with type 2 diabetes use metformin.

PHARMAC Chief Executive Steffan Crausaz and HRC Chief Executive Professor Kath McPherson announced the first recipients of the joint fund today.

Mr Crausaz says the two studies will provide valuable insights into how New Zealanders can get the best out of medicines.

“Our objective in setting up the fund with the HRC was to improve our knowledge of medicines use in New Zealand, so that we can take steps to improve people’s use of medicines,” he says.

“Metformin is an important medicine for people with type 2 diabetes, so Dr Parkin’s research will give us a better idea as to why people might not continue taking the medicine they need to keep them well.”

Dr McPherson says the collaboration with PHARMAC is providing a further opportunity to grow innovative research into pharmaceuticals in New Zealand.

“We’re delighted to be involved in this research initiative with PHARMAC. This is a great example of government health organisations collaborating to benefit patients and strengthen the use of research evidence to improve our health system overall.

“I’m confident that the studies funded through this partnership initiative will be of a high quality and add to our knowledge of how New Zealanders use medicines.”

Project details:

Improving metformin adherence and persistence in people with type 2 diabetes
$213,229, 24 months

Principal Investigator: Dr Lianne Parkin. The other investigators are Dr Simon Horsburgh (Preventive and Social Medicine), Mr Dave Barson (Preventive and Social Medicine), Associate Professor Katrina Sharples (Mathematics and Statistics, and Medicine), Dr Jimmy Zeng (Preventive and Social Medicine), Dr Lisa Te Morenga (Associate Dean (Māori), Division of Sciences; Edgar Diabetes and Obesity Research Centre; Human Nutrition), Faumuina Associate Professor Fa’afetai Sopoaga (Associate Dean (Pacific), Division of Health Sciences; Preventive and Social Medicine). Five of the researchers are core members of the Pharmacoepidemiology Research Network at the University.

Type 2 diabetes imposes a substantial burden on New Zealanders, particularly Māori and Pacific peoples. Metformin is the first-line medication for the treatment of type 2 diabetes, but overseas research has found that many patients have suboptimal metformin adherence and persistence. Persistence refers to whether a person stays on a therapy, while adherence refers to whether a person takes a medication according to the prescribed schedule. Suboptimal metformin adherence and persistence are important because they are associated with a higher risk of diabetes complications.

The researchers will use routinely collected health data to (a) describe the patterns of metformin adherence and persistence in New Zealanders with type 2 diabetes, and (b) investigate the predictors and consequences of suboptimal adherence and persistence. They will also interview people with type 2 diabetes to get their views on what helps, and hinders, good metformin adherence and persistence. The findings will contribute to improved outcomes for people prescribed metformin.

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Superu Report: Land Regulation Drives Auckland House Prices

Land use regulation is responsible for up to 56 per cent of the cost of an average house in Auckland according to a new research report quantifying the impact of land use regulations, Finance Minister Steven Joyce says. More>>

ALSO:

Fletcher Whittled: Fletcher Dumps Adamson In Face Of Dissatisfaction

Fletcher Building has taken the unusual step of dumping its chief executive, Mark Adamson, as the company slashed its full-year earnings guidance and flagged an impairment against Australian assets. More>>

ALSO:

No More Dog Docking: New Animal Welfare Regulations Progressed

“These 46 regulations include stock transport, farm husbandry, companion and working animals, pigs, layer hens and the way animals are accounted for in research, testing and teaching.” More>>

ALSO:

Employment: Most Kiwifruit Contractors Breaking Law

A Labour Inspectorate operation targeting the kiwifruit industry in Bay of Plenty has found the majority of labour hire contractors are breaching their obligations as employers. More>>

ALSO:

'Work Experience': Welfare Group Opposes The Warehouse Workfare

“This programme is about exploiting unemployed youth, not teaching them skills. The government are subsidising the Warehouse in the name of reducing benefit dependency,” says Vanessa Cole, spokesperson for Auckland Action Against Poverty. More>>

ALSO:

Internet Taxes: Labour To Target $600M In Unpaid Taxes From Multinationals

The Labour Party would target multinationals operating in New Zealand to ensure they don't avoid paying tax if it wins power and is targeting $600 million over three years through a "diverted profits tax," says leader Andrew Little. More>>

ALSO: